KMPR
CME

CRONIN KATHLEEN M

Known title: DirectorCIK: 0001259107

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

Kemper Q2 earnings reviewed alongside peers. Kemper Corporation's second-quarter results are being analyzed in comparison to other multi-line insurance companies. This review helps investors understand how KMPR performed relative to industry standards. The stock currently trades with a dividend yield of 2.91%, while analysts maintain an average price target of $36.33.

this person other insiders at KMPR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

CME Launches New Crypto Futures as Rate Hike Odds Shift. CME Group is launching new futures contracts for Uniswap and Bitcoin Cash, expanding its cryptocurrency portfolio. At the same time, the exchange's policy stance has shifted odds on Polymarket regarding future interest rate hikes. These developments occur as the market prepares for CME's upcoming third-quarter earnings report.

this person other insiders at CME

Transaction History

KMPR▲ Buy$0
KMPR▲ Buy$0
CME▲ Buy$590K
CME▼ Sell$204K
CME▼ Sell$0
CME▼ Sell$909K
CME▼ Sell$0
CME▼ Sell$59K
CME▼ Sell$76K
CME▼ Sell$76K
CME▲ Buy$0
CME▼ Sell$69K

We use analytics to understand how market-wall is used. No personal data is sold.